UMIN ID: UMIN000001999
Registered date:22/05/2009
The phase I,II clinical study of cancer vaccine for intractable malignant tumor expressing MAGE-A4-antigen
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Intractable malignant tumors expressing MAGE-A4 antigen |
| Date of first enrollment | 2009/04/01 |
| Target sample size | 18 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | CHP-MAGE-A4 injection of 100 µg CHP-MAGE-A4 injection of 300 µg CHP-MAGE-A4 injection of 300 µg and concomittant injection of OK-432 as an adjuvant |
Outcome(s)
| Primary Outcome | the adverse events and the ability to induce antigen specific immune responses |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | HIV positive, autoimmune diseases,pregnancy,breast feeding |
Related Information
| Primary Sponsor | Department of Surgical Oncology, Hokkaido University Graduate School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Department of Surgical Oncology, Hokkaido University Graduate School of Medicine |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Takahiro Tsuchikawa |
| Address | Japan |
| Telephone | |
| Affiliation | Hokkaido University Graduate School of Medicine Department of Surgical Oncology |
| scientific contact | |
| Name | Satoshi Kondo |
| Address | Kita-15,Nishi-7,kita-ku,Sapporo,Hokkaido,Japan Japan |
| Telephone | 011-706-7714 |
| Affiliation | Hokkaido University Graduate School of Medicine Department of Surgical Oncology |